![Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease | Pediatric Research Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpr.2018.44/MediaObjects/41390_2018_Article_BFpr201844_Fig1_HTML.jpg)
Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease | Pediatric Research
![Efficacy of the Delayed Use of Low-dose Aspirin in Intravenous Immunoglobulin Therapy for Acute-phase Kawasaki Disease | European Journal of Medical and Health Sciences Efficacy of the Delayed Use of Low-dose Aspirin in Intravenous Immunoglobulin Therapy for Acute-phase Kawasaki Disease | European Journal of Medical and Health Sciences](https://www.ejmed.org/public/journals/1/article_691_cover_en_US.jpg)
Efficacy of the Delayed Use of Low-dose Aspirin in Intravenous Immunoglobulin Therapy for Acute-phase Kawasaki Disease | European Journal of Medical and Health Sciences
![UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Image - Image of pharmaceutical, painkiller: 160586505 UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Image - Image of pharmaceutical, painkiller: 160586505](https://thumbs.dreamstime.com/b/aspirin-also-known-as-acetylsalicylic-acid-everyday-painkiller-used-to-treat-pain-fever-inflammation-specific-160586505.jpg)
UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Image - Image of pharmaceutical, painkiller: 160586505
![Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2FBF03262128/MediaObjects/40267_2012_2128_Tab1.jpg)
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
![UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Photography - Image of treatment, pain: 160586557 UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Photography - Image of treatment, pain: 160586557](https://thumbs.dreamstime.com/z/uk-oct-aspirin-acetylsalicylic-acid-england-aspirin-also-known-as-acetylsalicylic-acid-everyday-painkiller-used-to-treat-160586557.jpg)
UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Photography - Image of treatment, pain: 160586557
![High-Dose or Low-Dose Aspirin Application in the Initial Phase of Kawasaki Disease: A Meta-Analysis and Systematic Review High-Dose or Low-Dose Aspirin Application in the Initial Phase of Kawasaki Disease: A Meta-Analysis and Systematic Review](https://static-02.hindawi.com/articles/jchem/volume-2022/6303653/figures/6303653.fig.001.jpg)
High-Dose or Low-Dose Aspirin Application in the Initial Phase of Kawasaki Disease: A Meta-Analysis and Systematic Review
![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig1_HTML.png)
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
![Children | Free Full-Text | The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Children | Free Full-Text | The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic](https://www.mdpi.com/children/children-07-00185/article_deploy/html/images/children-07-00185-g001-550.jpg)
Children | Free Full-Text | The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic
![Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review | Archives of Disease in Childhood Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review | Archives of Disease in Childhood](https://adc.bmj.com/content/archdischild/106/7/662/F5.large.jpg)
Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review | Archives of Disease in Childhood
![Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan](https://www.frontiersin.org/files/Articles/522921/fped-08-00249-HTML-r1/image_m/fped-08-00249-t004.jpg)